Physician

Abdelwahab Meri, M.D.

According to 2025 Medicare claims, Abdelwahab Meri, M.D. (NPI: 1528076619) practices internal medicine in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is ABDEL-WAHAB MERI MD PC (NPI: 1679787170; TIN: 201500282) and primary practice location at 48307-4599. Meri is affiliated with the Arvon CIN (ACO ID: A1095) and McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Meri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 1,795 HCPCS/CPT codes, and received $102,737 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 8,486 prescription claims across 436 beneficiaries totaling $902,956 in drug costs, led by Eliquis (Apixaban). DME data shows 98 claims. Open Payments data shows 39 records totaling $683. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $615,082 to $902,956. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,663 and ending at $11,076.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	297	2,268	$111,914
2016	296	2,312	$116,600
2017	264	2,079	$113,922
2018	246	1,686	$90,216
2019	246	2,055	$110,616
2020	232	1,552	$98,853
2021	248	1,588	$106,817
2022	246	1,343	$93,323
2023	221	2,310	$101,981
2024	220	1,795	$102,737

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	337	7,685	$615,082
2016	348	7,954	$562,130
2017	334	7,644	$584,492
2018	321	7,511	$630,288
2019	344	7,921	$629,319
2020	453	8,285	$681,746
2021	401	7,554	$710,942
2022	456	7,597	$758,614
2023	403	7,799	$909,160
2024	436	8,486	$902,956

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	267	$4,598
2016	61	291	$4,506
2017	46	233	$3,616
2018	42	185	$3,201
2019	41	354	$64,137
2020	31	241	$59,681
2021	16	210	$5,320
2022	15	162	$5,194
2023	25	136	$7,281
2024	13	98	$9,230

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	52	62	$138
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	75	75	$130
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	57	263	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	173	416	$90
81002	Urinalysis, manual test	76	102	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	146	7,071	$130,353
Mounjaro	Tirzepatide	58	2,100	$76,978
Repatha Sureclick	Evolocumab	86	3,192	$60,835
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	13	390	$52,024
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	1,950	$39,948

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$7,590
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$760
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	22	$415
K0001	Standard wheelchair	Y	N/R	16	$248
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$164

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$683	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdelwahab Meri, M.D.?

Tedicare shows public-source Medicare data for Abdelwahab Meri, M.D. (NPI 1528076619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdelwahab Meri, M.D. have ACO affiliation data?

Abdelwahab Meri, M.D. is shown with ACO affiliation data for Arvon CIN (MSSP, ACO ID A1095) and McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Abdelwahab Meri, M.D.?

Abdelwahab Meri, M.D. is linked to ABDEL-WAHAB MERI MD PC (billing NPI 1679787170) in the available physician profile data.

Does Abdelwahab Meri, M.D. have Open Payments data?

Abdelwahab Meri, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.